NURSING STANDARD
USING AN INHALER device correctly is essential to ensure maximum benefit from inhaled medication. If an inhaler is not used correctly the drug can be wasted, there can be unnecessary cost to the patient and health service and limitations to lifestyle as a result of poor asthma control (National Institute for Clinical Excellence (NICE) 2000, 2002) . Guidelines for asthma (British Thoracic Society and Scottish Intercollegiate Guidelines Network (BTS/SIGN) 2005) and for chronic obstructive pulmonary disease (COPD) (National Collaborating Centre for Chronic Conditions (NCCCC) 2004) stress the need for instruction and training in the use of inhalers and the importance of patients being able to demonstrate satisfactory technique. NICE (2002) acknowledges the importance of involving the patient and carers in the choice of device and the need to check technique regularly. This is also recognised in the Quality and Outcomes Framework -a component of the new General Medical Services contract -where checking the inhaler technique is included as a separate item for patients with COPD, and forms part of the recommendations for the asthma review (British Medical Association and NHS Confederation 2003) .
For inhaled medication to be effective, it is essential that the device not only delivers consistent doses of the medication but that it can be easily and willingly used by the individual. An inhaler can only be effective if it is being used appropriately. To help patients choose the most effective inhaler device health professionals should have good knowledge of the drug required, the range of devices available and issues such as cost effectiveness and local formulary recommendations. Practical expertise in the use of different inhalers is necessary as is the need to take into account factors such as the patient's age, manual dexterity, lifestyle and attitude to treatment.
Drug availability
Pressurised metered dose inhalers A wide range of therapies is available in pressurised metered dose inhalers (pMDIs) ( Table 1 ) and for some therapies may be the lowest cost option, initially making them appear an appropriate choice for many patients. These inhalers, however, require good co-ordination between the actuation of the inhaler and inspiration making them difficult to use for many individuals. The aerosol leaves the actuator of a pMDI at high speed and so inhalation at a low inspiratory flow rate is required to minimise oro-pharyngeal deposition and maximise peripheral lung deposition. This is particularly important with inhaled corticosteroids where oro-pharyngeal deposition can cause local side effects such as dysphonia (hoarse voice) or oral candidiasis (thrush). It is also important that inhaled corticosteroids reach smaller and more peripheral airways because inflammation has been shown to extend beyond larger airways.
The use of a spacer device can aid co-ordination and help to slow down aerosol delivery. Spacer devices are holding chambers which trap the medication after it is released from a pMDI, allowing more time for medication to be inhaled. 
Correct technique for using aerosol inhaler devices
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The device is particularly useful when co-ordination is a problem, high doses of inhaled corticosteroids are required or for young children. There is a range of small and large volume spacer devices available to use with pMDIs but not all pMDI devices fit all spacers and the effectiveness of the device may be altered.
A pMDI used in conjunction with a spacer and a mask, as appropriate, is generally the first choice of delivery system for all therapies in children under five years (NICE 2000) . In children aged 5-15 years, NICE (2002) suggests that a pMDI and spacer should remain the first choice for inhaled corticosteroid therapy, if acceptable to the child and family, but that alternative devices can be considered for bronchodilator therapy. The BTS/SIGN (2005) guidelines suggest that for adults a pMDI and spacer are as effective as any other hand-held inhaler but that patients may prefer other types of inhaler. For example, it is important to consider lifestyle factors, because a spacer can be more bulky and less portable than other options. It may be suitable for regular preventive therapy if the individual does not need to travel away from home regularly. Patient preference and assessment of correct use are key factors when choosing an inhaler device. Operating pressurised metered dose inhalers Depression and operation of the pMDI canister require good manual dexterity. This may make using the pMDI device unaided difficult for those with a disability as a result of conditions such as rheumatoid arthritis or stroke. In such cases a haleraid device can be used. The device fits over the pMDI allowing it to be operated by a gentle squeezing action rather than a pushing down action. The device is not available on prescription but can be obtained from most pharmacists for a small cost.
Key points to consider when using a pMDI include:
Good co-ordination is required for effective use.
The most common error is to breathe in too fast.
Teeth and the tongue can obstruct the flow of spray.
The device can be used with a spacer with or without a mask.
Most pMDIs do not have a dose counter, which can make it difficult to tell when the device is empty. The salmeterol and fluticasone combination pMDI has a counter which counts down from 120 doses.
Dysphonia and candidiasis can result from the use of some inhaled corticosteroids but may be reduced by the use of a spacer and/or rinsing the mouth after use.
Not all pMDIs contain the same number of doses.
Extremes of temperature should be avoided and it is important that the canister is not pierced or burnt even when empty. the Easi-Breathe ® . The range of drugs available in these devices is more limited than for pMDIs but includes a reliever and a preventer medication ( Table 2) . The Autohaler ® and the Easi-Breathe ® devices remove the need for co-ordination between actuation and inhalation, and therefore co-ordination, and so may be easier to use than pMDIs. The Easi-Breathe ® inhaled corticosteroid inhaler is supplied with an extension tube or optimiser, which acts like a small spacer reducing the speed of the spray. This is designed to minimise oral pharyngeal deposition and so reduce the potential risk of oral candidiasis and dysphonia.
Breath-activated devices
Key points to consider when using an Autohaler ® pMDI include:
The device is easy to use and little if any co-ordination is required.
No dose counter is available, so it may be difficult to tell when the inhaler is empty.
If new, or if not used for two weeks, prime using the slide device on the bottom of the casing to ensure correct dose is administered.
There is a need to continue to breathe in while the inhaler makes a clicking noise, which indicates that the drug is being released.
The inhaler should be cleaned by wiping with a dry cloth only. It is important not to put any part of the device in water.
Extremes of temperature should be avoided and it is important that the canister is not pierced or burnt even when empty.
Key points to consider when using an Easi-Breathe ® pMDI include:
An optimiser extension tube can be supplied with inhaled corticosteroid.
The inhaler base can be washed following the manufacturer's instructions but it is important that the top of the body casing remains dry as specified in the manufacturer's instructions.
Chlorofluorocarbon (CFC)-free versions should be test fired when new or if not used for one week to ensure effective dosing.
Conclusion
The most effective inhaler device for any patient is one that the individual can and will continue to use to deliver the right amount of medication consistently. It must be remembered that costeffective prescribing involves more than simply issuing a prescription for the cheapest available option; it also considers effectiveness, which includes maximising patient adherence and comfort with the chosen device.
It is also important to ensure that the patient receives the device as chosen so care must be taken when issuing prescriptions as, for example, 'breath-actuated' can refer to either the Easi-Breathe ® or Autohaler ® device. Aerosol inhalers with and without a spacer can be used to deliver inhaled medication effectively but individual patient assessment is required initially to determine suitability of the device. Regular teaching and checking of technique are essential to maintain the ongoing effectiveness of therapy NS
